KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Payables (2016 - 2025)

Pacific Biosciences Of California has reported Payables over the past 16 years, most recently at $20.8 million for Q4 2025.

  • Quarterly results put Payables at $20.8 million for Q4 2025, up 25.2% from a year ago — trailing twelve months through Dec 2025 was $20.8 million (up 25.2% YoY), and the annual figure for FY2025 was $20.8 million, up 25.2%.
  • Payables for Q4 2025 was $20.8 million at Pacific Biosciences Of California, up from $16.4 million in the prior quarter.
  • Over the last five years, Payables for PACB hit a ceiling of $21.0 million in Q1 2024 and a floor of $3.5 million in Q1 2021.
  • Median Payables over the past 5 years was $15.6 million (2023), compared with a mean of $14.6 million.
  • Biggest five-year swings in Payables: tumbled 35.97% in 2021 and later skyrocketed 407.26% in 2022.
  • Pacific Biosciences Of California's Payables stood at $12.6 million in 2021, then increased by 13.62% to $14.3 million in 2022, then rose by 8.61% to $15.6 million in 2023, then increased by 6.61% to $16.6 million in 2024, then increased by 25.2% to $20.8 million in 2025.
  • The last three reported values for Payables were $20.8 million (Q4 2025), $16.4 million (Q3 2025), and $15.1 million (Q2 2025) per Business Quant data.